Data investigation

Eight Things Patients Said

Trials measure weight and adverse events. They do not measure being judged for taking a drug. Researchers interviewed 30 people across 15 states and sorted what they said into eight themes.

By Nora Bissett · Pricing Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
6 min read·1 citation

Trials measure weight and adverse events. They do not measure being judged for taking a drug, or being handed a prescription with no explanation of what to expect. Researchers interviewed 30 people across 15 states who were taking or had taken a GLP-1, and sorted what they said into eight themes.[1] Several are things no randomized trial can see.

This is a qualitative study, and it does not produce percentages. Thirty people, recruited through a research volunteer registry and word of mouth, are a self-selected group and are not meant to represent anyone. What thematic analysis yields is the range of experiences and their shape, not how common each one is. Nothing below should be read as “most people.”

What the drug does, in patients' words

The first theme is the one that has already escaped into common usage: a reduction in food noise, the constant background negotiation with eating that people describe going quiet. It arrived as patient vocabulary before it had any research instrument behind it, which is unusual, and it now has one. We cover that separately in food noise, what it is.

The second is a corrective that participants themselves supplied. These drugs are not a standalone weight loss solution. Two more themes run alongside both: the wide range of adverse effects people experienced, and their readiness to put up with them, and with logistical difficulty, to get the result.

The half trials cannot measure

The second group of themes is about everything surrounding the prescription, and it is where this study earns its place.

The social, clinical and structural themes, as reported.[1]
ThemeWhat it describes
Stigma, varying by indicationPerceived stigma about taking a GLP-1, influenced by what it was prescribed for
Clinical supportInformation provision and support described as essential but highly variable
AccessCost and availability described as prohibitive
Shared experienceValue placed on hearing from others in the same position

The first row matters most. The same molecule, at the same dose, is a different social object depending on why it was prescribed. Taken for type 2 diabetes it reads as treating an illness; taken for weight it invites a judgment about character. Nobody can randomize that, and it plainly affects whether people start, disclose, or continue.

Perceived stigma about taking a GLP-1 varied with what it was prescribed for, such as type 2 diabetes or weight.

'Essential but highly variable'

That phrase describes the gap this register exists in. Participants regarded good information and clinical support as necessary to using these drugs well, and reported getting wildly different amounts of it.

It is a predictable consequence of how these prescriptions are written. A drug dispensed through a fifteen-minute telehealth appointment, a specialist clinic, and a primary care visit are three different experiences of the same medicine, and only one of them reliably includes someone explaining that the nausea peaks at each dose increase, or that stopping brings the weight back. Compounded prescriptions from the telehealth route are also mostly missing from primary care records.

If you are buying online, one way to tilt the odds is to check whether coaching is part of what you pay for. Livbetr pairs patients with a one-to-one care coach, and Lighter You adds care coaching and dietitian visits to its membership. Eloria, BeyondMD and eMI Aesthetics also list coaching among what the program includes.

A few build the support around regular contact. At Marek Health a health coach checks in monthly and labs repeat on a schedule, though a lab panel is required before care begins. Reset Solutions starts with a telehealth consult and an in-person kickoff at its clinic in Shenandoah, Texas, with coaching in the program fee and medication billed separately. TeleFirst Med, a small North Carolina virtual clinic, describes coaching and nutrition plans in its weight program but names no GLP-1 drug.

Coaching does not always come with a membership fee attached. WeightlessRx includes nutrition coaching with its compounded semaglutide and tirzepatide, which it sells in 3-month supplies with no membership fee.

The last theme, the value people placed on shared experience, follows from that gap and cuts both ways. Peer accounts fill a real vacuum. They also carry the distortions documented elsewhere, where a platform’s coverage of this drug omitted its most common side effects entirely: what Instagram leaves out.

What to do with a study like this

  • Use it for the questions, not the numbers. It tells you what to ask a prescriber about, not how likely anything is.
  • Take the stigma finding seriously. It is a real barrier that no clinical measure captures and that plenty of people will not raise unprompted.
  • Treat “highly variable” as actionable. If nobody has explained the titration schedule, what side effects to expect and when, or what happens when you stop, that is missing care and it is reasonable to ask for it.
  • Do not generalize the sample. Thirty volunteers averaging 54 years old are not a cross-section of anyone.

Frequently Asked Questions

The themes included a reduction in food noise, a clear sense that the drugs are not a standalone solution, and a willingness to tolerate substantial side effects and logistical difficulty to get the result.
Participants described perceived stigma that varied according to what the drug was prescribed for. The same medicine at the same dose is received differently depending on whether it is being taken for diabetes or for weight.
Described as essential and highly variable. What someone is told about titration, side effects and stopping depends heavily on where the prescription came from.
No. Thematic analysis of 30 self-selected volunteers identifies the range and shape of experiences, not their prevalence. It should not be read as describing most patients.
Because it captures what trials do not measure: stigma, the quality of clinical support, and what people are willing to endure. Those determine whether someone starts and continues a treatment, and no trial randomizes them.

References

  1. 1.de Vere Hunt I, Ramirez-Posada M, Babu CS, et al. Patient Experiences With GLP-1 Receptor Agonists JAMA Network Open. 2026. PMID: 42247231.

Judged Worse Than Not Losing Weight

Researchers gave 607 people identical descriptions of a stranger, varying only how they had lost weight. The version who used a GLP-1 was judged more harshly than the version who had not lost weight at all.

6 min read

A Quarter the Odds of Being Offered It

People with diabetes who also have a mental health diagnosis received worse care on almost every measure, and a quarter of the odds of being prescribed a GLP-1, while having half again the odds of being put on insulin.

7 min read

Antipsychotics and Metabolic Harm

The drugs that work best for schizophrenia are the hardest on metabolism, and switching is often not an option. A Danish trial treated the consequence instead, and measured psychiatric symptoms as an outcome.

7 min read

Real, and Below the Threshold

Semaglutide improves patient-reported physical functioning by 1.71 points, with an interval excluding zero. The threshold at which a patient notices a change is 3.7 points. Both are true at once.

6 min read

The Mental Health Score That Did Not Move

In the head-to-head trial, physical quality-of-life scores improved clearly over 72 weeks. The Mental Component Summary did not significantly improve in either arm, a result the paper's own conclusion omits.

6 min read

Does Ozempic or Mounjaro Cause Anxiety? What the Trials and Labels Show

In randomized trials, anxiety was no more common on semaglutide or tirzepatide than on placebo. Where cohort studies and adverse-event reports disagree, why low blood sugar and a faster pulse can feel like anxiety, and what is known about panic attacks.

12 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.9

Luvo Health

Moving between compounded and brand without changing seller

7.1

Direct Meds

Compounded semaglutide at $249/month

8.2

HealthRX

Compounded semaglutide at $165/month after a $99 first month

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →